| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 101.733 | 203.923 | 386.516 | 3.245.357 |
| Total Income - EUR | - | - | - | - | - | - | 101.733 | 209.757 | 389.213 | 3.263.246 |
| Total Expenses - EUR | - | - | - | - | - | - | 86.872 | 200.788 | 374.975 | 3.123.665 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 14.862 | 8.969 | 14.238 | 139.581 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 13.844 | 6.950 | 10.540 | 111.048 |
| Employees | - | - | - | - | - | - | 3 | 2 | 3 | 7 |
Check the financial reports for the company - Surdu Intermed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | -10 | -158 | 1.331 | 2.439 |
| Current Assets | - | - | - | - | - | - | 74.869 | 24.528 | 75.870 | 607.032 |
| Inventories | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | - | 55.405 | 16.605 | 50.444 | 585.629 |
| Cash | - | - | - | - | - | - | 19.464 | 7.923 | 25.425 | 21.402 |
| Shareholders Funds | - | - | - | - | - | - | 13.885 | 6.999 | 10.589 | 108.666 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 62.482 | 18.059 | 68.977 | 502.117 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "5229 - 5229" | |||||||||
| CAEN Financial Year |
5229
|
|||||||||
Comments - Surdu Intermed S.r.l.